Chembio Diagnostics Inc. appointed John Potthoff to its board.

Potthoff is the CEO of Elligo Health Research Inc., a clinical research company in Austin, Texas.

Medford, N.Y.-based Chembio Diagnostics develops point-of-care diagnostic tests that are used to detect or monitor diseases.